BriaCell Therapeutics Corp. — Form D

BriaCell Therapeutics Corp. of WEST VANCOUVER, A1, a company, filed a Form D exempt-offering notice with the SEC on 2018-04-10. The offering totals $800K, of which $800K was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (28)

Showing 25 of 28 people.

NameRoleLocation
Saeid BabaeiDirectorWest Vancouver, A1
Martin V SchmiegDirectorWest Vancouver, A1
Rahoul V SharanDirectorWest Vancouver, A1
William V WilliamsDirectorAtlanta, GA
Charles WisemanDirectorWest Vancouver, A1
Gadi V LevinExecutive OfficerWest Vancouver, A1
William V WilliamsExecutive OfficerAtlanta, GA
Vaughn Embro-PantalonyDirectorMississauga, A6
Gadi LevinExecutive OfficerMa'anit, L3
Martin SchmiegDirectorWest Vancouver, A1
William WilliamsDirectorWest Vancouver, A1
William WilliamsExecutive OfficerWest Vancouver, A1
Jamieson BondarenkoDirectorWest Vancouver, A1
Jamieson BondarenkoExecutive OfficerWest Vancouver, A1
Rebecca TaubDirectorWest Vancouver, A1
Charles WisemanExecutive OfficerWest Vancouver, A1
Rahoul A SharanDirectorWest Vancouver, A1
Rahoul A SharanExecutive OfficerWest Vancouver, A1
Isaac A MareskyDirectorWest Vancouver, A1
Saeid BabeiDirectorWest Vancouver, A1
Chris G HealeyDirectorWest Vancouver, A1
Matthew G WrightExecutive OfficerWest Vancouver, A1
Jevin WerbesDirectorWest Vancouver, A1
Jevin WerbesExecutive OfficerWest Vancouver, A1
Rahoul SharanDirectorWest Vancouver, A1

Other filings by this issuer (3)

FiledFormOfferingSold
2021-06-15D$27.2M$27.2M
2014-12-12D$6.0M$6.0M
2014-06-20D$881K$299K

More